Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02288702 · ClinicalTrials.gov registry record
Comparison of Bispectral Index Values in Patients With and Without Down's Syndrome
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- 40
- Enrollment target
NCT02288702 is a clinical trial that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT02288702 was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
About 1 in every 700 babies born in the United States has Down's Syndrome (DS; Trisomy 21), 99% of whom have some degree of intellectual disability. Recent advances in medicine have resulted in a dramatically improved lifespan of about 25 to 60 years of age. Yet, there is limited data about anesthetic management in this increasing patient population. The bispectral index (BIS) monitor is a non-invasive monitoring device that reports a value between 0 and 100correlating to level of consciousness of an individual. A value of 0 indicates lack of brain activity while 100 indicates an awake/alert state. This monitor can be used to assess the depth of anesthesia. Patients with intellectual disability from congenital neurological diseases have lower BIS values compared to patients without any neurological impairment (Valkenburg 2009). The results may suggest that DS patients would require less anesthetic drugs compared to patients without any neurological impairment. To date, there are no studies in DS patients.
Interventions
- DEVICE monitoring BIS in both groups
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-07-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02288702
The ClinicalTrials.gov registry entry for NCT02288702 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which monitoring BIS in both groups is the first listed.
NCT02288702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02288702 about?
NCT02288702 is a clinical study titled "Comparison of Bispectral Index Values in Patients With and Without Down's Syndrome". About 1 in every 700 babies born in the United States has Down's Syndrome (DS; Trisomy 21), 99% of whom have some degree of intellectual disability. Recent advances in medicine have resulted in a dramatically improved lifespan of about 25 to 60 years of age. Yet, there is limited data about anesthet...
What is the current status of trial NCT02288702?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2014-10. Estimated completion is 2017-07-13.
What interventions are being tested in trial NCT02288702?
The interventions under investigation include: monitoring BIS in both groups (DEVICE).
Who is sponsoring clinical trial NCT02288702?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.